tiprankstipranks
NuCana price target lowered to $20 from $150 at Truist
PremiumThe FlyNuCana price target lowered to $20 from $150 at Truist
2M ago
NuCana plc Enhances Offering to $5.4 Million
Premium
Company Announcements
NuCana plc Enhances Offering to $5.4 Million
3M ago
NuCana Secures US Patent for Promising Cancer Drug
Premium
Company Announcements
NuCana Secures US Patent for Promising Cancer Drug
3M ago
NuCana Reports Breakthrough in Resistant Melanoma Treatment
PremiumCompany AnnouncementsNuCana Reports Breakthrough in Resistant Melanoma Treatment
3M ago
NuCana presents Data on NUC-7738 in combination with Pembrolizumab
Premium
The Fly
NuCana presents Data on NUC-7738 in combination with Pembrolizumab
3M ago
NuCana price target lowered to $25 from $150 at Oppenheimer
Premium
The Fly
NuCana price target lowered to $25 from $150 at Oppenheimer
4M ago
NuCana downgraded to Market Perform from Outperform at William Blair
PremiumThe FlyNuCana downgraded to Market Perform from Outperform at William Blair
4M ago
NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments
Premium
Company Announcements
NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments
4M ago
NuCana PLC (ADR) trading resumes
Premium
The Fly
NuCana PLC (ADR) trading resumes
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100